Dong Lu

4.1k total citations
100 papers, 3.0k citations indexed

About

Dong Lu is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Dong Lu has authored 100 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 18 papers in Oncology and 16 papers in Hepatology. Recurrent topics in Dong Lu's work include Computational Drug Discovery Methods (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Protein Degradation and Inhibitors (8 papers). Dong Lu is often cited by papers focused on Computational Drug Discovery Methods (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Protein Degradation and Inhibitors (8 papers). Dong Lu collaborates with scholars based in China, United States and United Kingdom. Dong Lu's co-authors include Pentao Liu, Elena Vigorito, Rebecca Leyland, Susan Kohlhaas, Xinjie Lu, Allan Bradley, Lia S. Campos, Vijay V. Kakkar, Zemin Ning and David Melvin and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Chemical Society Reviews.

In The Last Decade

Dong Lu

98 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong Lu China 26 1.8k 454 433 409 265 100 3.0k
Xin Hu United States 28 1.5k 0.8× 743 1.6× 272 0.6× 383 0.9× 131 0.5× 109 3.5k
Qianqian Zhu China 35 1.9k 1.1× 549 1.2× 437 1.0× 938 2.3× 344 1.3× 159 3.9k
M. Teresa Pisabarro Germany 38 3.6k 2.0× 380 0.8× 537 1.2× 486 1.2× 421 1.6× 100 5.0k
Yonghui Zhang China 35 1.6k 0.9× 217 0.5× 511 1.2× 199 0.5× 94 0.4× 94 3.2k
Kevin A. Janes United States 30 3.3k 1.8× 516 1.1× 539 1.2× 335 0.8× 285 1.1× 65 5.8k
Aleksandr Ianevski Finland 23 1.5k 0.8× 335 0.7× 557 1.3× 300 0.7× 107 0.4× 54 2.8k
Manoj Garg India 39 2.4k 1.4× 570 1.3× 668 1.5× 990 2.4× 156 0.6× 100 3.9k
Kip A. West United States 22 3.4k 1.9× 385 0.8× 1.1k 2.5× 448 1.1× 420 1.6× 30 4.9k
Alessandro Datti Canada 36 2.7k 1.5× 328 0.7× 812 1.9× 618 1.5× 201 0.8× 97 4.1k
Scott J. Snipas United States 31 2.8k 1.6× 841 1.9× 615 1.4× 602 1.5× 224 0.8× 58 4.0k

Countries citing papers authored by Dong Lu

Since Specialization
Citations

This map shows the geographic impact of Dong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Lu more than expected).

Fields of papers citing papers by Dong Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Lu. The network helps show where Dong Lu may publish in the future.

Co-authorship network of co-authors of Dong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Lu. A scholar is included among the top collaborators of Dong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Lu. Dong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Dong, Hanfeng Lin, Ran Cheng, et al.. (2025). Design, Optimization, and Development of RIPK1 Degraders with Improved Pharmacokinetic and Pharmacodynamic Properties. Journal of Medicinal Chemistry. 68(21). 22246–22263. 1 indexed citations
2.
Wu, Xinru, Dong–Hau Kuo, Pengkun Zhang, et al.. (2025). A Mo-cation/O-anion doping strategy for creating vacancy defects and cation multivalency to enhance the hydrogen evolution of ZnS under visible light. Journal of Materials Chemistry A. 13(23). 17976–17991. 11 indexed citations
3.
Wagner, Jennifer K., David W. Vredevoogd, Xin Yu, et al.. (2025). TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors. Cell Death and Disease. 16(1). 35–35. 5 indexed citations
4.
Lu, Dong, Jing-Yuan Liu, Gao‐Qian Wang, et al.. (2024). Identification of three novel P450 enzymes involved in the oxidative modification of a newly discovered fusicoccane diterpene. Bioorganic Chemistry. 152. 107726–107726. 2 indexed citations
5.
Tie, Jun, et al.. (2021). An In Vitro Comparative Study of Three Drug-Eluting Beads Loaded with Raltitrexed. Cancer Biotherapy and Radiopharmaceuticals. 38(9). 641–649. 3 indexed citations
6.
7.
Ji, Xuemeng, Ping Lu, Yaozhong Hu, et al.. (2021). Function Characterization of Endogenous Plasmids in Cronobacter sakazakii and Identification of p-Coumaric Acid as Plasmid-Curing Agent. Frontiers in Microbiology. 12. 687243–687243. 12 indexed citations
8.
Ding, Nan, Junrui Hua, Jinpeng He, et al.. (2020). The Role of MiR-5094 as a Proliferation Suppressor during Cellular Radiation Response via Downregulating STAT5b. Journal of Cancer. 11(8). 2222–2233. 2 indexed citations
9.
Zhang, Guoqing, Jing Xing, Yulan Wang, et al.. (2018). Discovery of Novel Inhibitors of Indoleamine 2,3-Dioxygenase 1 Through Structure-Based Virtual Screening. Frontiers in Pharmacology. 9. 277–277. 23 indexed citations
10.
Zhong, Feisheng, Jing Xing, Xutong Li, et al.. (2018). Artificial intelligence in drug design. Science China Life Sciences. 61(10). 1191–1204. 158 indexed citations
11.
Lu, Jing, Dong Lu, Zunyun Fu, Mingyue Zheng, & Xiaomin Luo. (2018). Machine Learning-Based Modeling of Drug Toxicity. Methods in molecular biology. 1754. 247–264. 16 indexed citations
12.
Yang, Liu, Peng Xia, Dong Lu, et al.. (2016). Discovery of novel Ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors. European Journal of Medicinal Chemistry. 126. 122–132. 11 indexed citations
13.
Zhang, Miaomiao, et al.. (2015). Effects of X-ray and carbon ion beam irradiation on membrane permeability and integrity in Saccharomyces cerevisiae cells. Journal of Radiation Research. 56(2). 294–304. 23 indexed citations
14.
Lv, Wei‐Fu, et al.. (2015). Imaging features of primary hepatic leiomyosarcoma: A case report and review of literature. Oncology Letters. 9(5). 2256–2260. 17 indexed citations
15.
Chew, Su Kit, Dong Lu, Lia S. Campos, et al.. (2014). Polygenic in vivovalidation of cancer mutations using transposons. Genome biology. 15(9). 455–455. 3 indexed citations
16.
Wang, Wei, Jian Yang, Hui Liu, et al.. (2011). Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proceedings of the National Academy of Sciences. 108(45). 18283–18288. 193 indexed citations
17.
Li, Peng, Shannon Burke, Juexuan Wang, et al.. (2010). Reprogramming of T Cells to Natural Killer–Like Cells upon Bcl11b Deletion. Science. 329(5987). 85–89. 267 indexed citations
18.
Lu, Dong. (2009). Selective uterine artery embolization for treatment of symptomatic uterine fibroids. 1 indexed citations
19.
Lu, Xinjie, et al.. (2008). ADAM Proteins- Therapeutic Potential in Cancer. Current Cancer Drug Targets. 8(8). 720–732. 38 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xin Hu Breakdown of academic impact, for papers by Qianqian Zhu Breakdown of academic impact, for papers by M. Teresa Pisabarro Breakdown of academic impact, for papers by Yonghui Zhang Breakdown of academic impact, for papers by Kevin A. Janes Breakdown of academic impact, for papers by Aleksandr Ianevski Breakdown of academic impact, for papers by Manoj Garg Breakdown of academic impact, for papers by Kip A. West Breakdown of academic impact, for papers by Alessandro Datti Breakdown of academic impact, for papers by Scott J. Snipas
Rankless by CCL
2026